Exploratory Magnetic Resonance Imaging Endpoints from NOVA: A Randomised Controlled Study of the Efficacy of 6-week Dosing of Natalizumab vs Continued 4-week Treatment for Multiple Sclerosis

28. októbra 2022 1 videnie
Arnold DL et al.

Skrátená informácia o lieku

tysabri avonex tecfidera fampyra plegridy
2012 - 2024 Copyright Farmi-Profi, spol. s r.o - Všetky práva vyhradené - Made by Elite ML